PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection

Cited by (889)

Items 701–800 of 889

1. Fallen Angels or Risen Apes? A Tale of the Intricate Complexities of Imbalanced Immune Responses in the Pathogenesis and Progression of Immune-Mediated and Viral Cancers
   Beatrice Ondondo · 2014 · Frontiers in Immunology
2. Animal models for viral infection and cell exhaustion
   Colleen S. McGary, Guido Silvestri, Mirko Paiardini · 2014 · Current Opinion in HIV and AIDS
3. The Role of Exhaustion in Tumor-Induced T-Cell Dysfunction in Cancer
   Heriberto Prado-Garcı́a, Susana Romero‐Garcia · 2020 · Springer eBooks
4. Neuroimmune-Endocrine Modulation of T-Cell Exhaustion in Central Nervous System Parasitic Diseases: Insights from Toxoplasmosis and Neurocysticercosis
   Ivan Nicolás Pérez‐Osorio, Juan Alberto Hernández-Aceves, Alejandro Espinosa, Rafael Saavedra, Gladis Fragoso, Edda Sciutto · 2025 · NeuroImmunoModulation
5. The prospect of targeting T cell immunoglobulin and mucin‐domain containing‐3 in renal cell carcinoma immunotherapy
   Monireh Mohsenzadegan, Mohammad Reza Nowroozi, Amirreza Fotovvat, Parizad Bavandpour Baghshahi, Saied Bokaie, Seyed Hassan Inanloo, Laleh Sharifi · 2022 · Scandinavian Journal of Immunology
6. T-Cell Dysfunction in HIV-1 Infection: Targeting the Inhibitors
   Jocelyn S. Downey, Nesrina Imami · 2009 · HIV Therapy
7. T-cell responses in primary HIV-1 infection
   Hendrik Streeck, David J van Bockel, Anthony Dominic Kelleher · 2008 · Current Opinion in HIV and AIDS
8. Fighting with the Enemys Weapons? The Role of Costimulatory Molecules in HIV
   Brenda De Keersmaecker, Kristiaan Thielemans, Joeri L. Aerts · 2011 · Current Molecular Medicine
9. CD8 TCR β chain repertoire expansions and deletions are related with immunologic markers in HIV-1-infected patients during treatment interruption
   Alejandro González‐Serna, María Abad-Fernández, Natalia Soriano-Sarabia, Manuel Leal, Alejandro Vallejo · 2013 · Journal of Clinical Virology
10. Role of IL-21 in HTLV-1 infections with emphasis on HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
    Taraneh Rajaei, Hamid Farajifard, Houshang Rafatpanah, Reza Bustani, Narges Valizadeh, Bahareh Rajaei, Seyed Abdolrahim Rezaee · 2017 · Medical Microbiology and Immunology
11. Immune Correlates of Herpes Zoster in People Living with HIV on Effective Antiretroviral Therapy
    Adriana Tovar-Salazar, Ashley McKhann, Huichao Chen, Ronald J. Bosch, Adriana Weinberg · 2019 · AIDS Research and Human Retroviruses
12. Phenotypic and functional analysis of LCMV gp33-41-specific CD8 T cells elicited by multiple peptide immunization in mice revealed the up-regulation of PD-1 expression on antigen-specific CD8 T cells.
    Yi Liu, Lihui Xu, Yiqun Jiang, Jianfang Sun, Xian‐Hui He · 2007 · PubMed
13. Immunology of HIV
    Heribert Stoiber, Doris Wilflingseder · 2011 · Springer eBooks
14. Regulation of immune responses, apoptosis, and tumorigenesis by separate FOXP-3-dependent genes: Connection with clinical manifestations
    Oxana V. Klimenko · 2011 · Journal of Microbiology Immunology and Infection
15. Identification of Three Immunologic Correlates for HIV Type 1 Pathogenesis in Youth
    Wei Song, Yufeng Li, Craig M. Wilson, Jianming Tang · 2010 · AIDS Research and Human Retroviruses
16. BACH2-driven tissue resident memory programs promote HIV-1 persistence
    Yulong Wei, Haocong Katherine Ma, Michelle E. Wong, Emmanouil Papasavvas, Liza Konnikova, Pablo Tebas, Ricardo Morgenstern, Luis J. Montaner, Ya‐Chi Ho · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
17. HIV-related Differences in Placental Immunology: Data From the PRACHITi Cohort in Pune, India
    Jyoti S. Mathad, Mallika Alexander, Ramesh A. Bhosale, Shilpa Naik, Lisa Marie Cranmer, Vandana Kulkarni, Sydney Busch, Andrea Chalem, Emily Shira Gitlin, Jun Lei et al. · 2025 · Open Forum Infectious Diseases
18. Galectin 9 Levels as a Potential Predictor of Intact HIV Reservoir Decay
    Sergio Serrano Villar, Akshay Gala, Peter Bacchetti, Rebecca Hoh, Clara Di Germanio, Lillian B. Cohn, Timothy J. Henrich, Peter W. Hunt, Gregory M. Laird, Satish K. Pillai et al. · 2024 · The Journal of Infectious Diseases
19. Immune Co-signaling to Treat Cancer
    Margaret K. Callahan, Jedd D. Wolchok, James Patrick Allison, Padmanee Sharma · 2012 · Springer eBooks
20. Pathogenesis of HIV-1 infection – chosen aspects
    B. Knysz, B. Szetela, A. Gładysz · 2007 · HIV & AIDS Review
21. Antibodies to gp120 and PD-1 Expression on Virus-Specific CD8 + T Cells in Protection from Simian AIDS
    Monica Vaccari, Rabih Halwani, L. Jean Patterson, Adriano Boasso, Jennifer Beal, Elżbieta Anna Tryniszewska, Anna Hryniewicz, David J. Venzon, Elias K. Haddad, Mohamed El Far et al. · 2013 · Journal of Virology
22. The inhibitor of apoptosis proteins antagonist Debio 1143 promotes the PD-1 blockade-mediated HIV load reduction in blood and tissues of humanized mice
    Michael D. Bobardt, Joseph Kuo, Udayan Chatterji, Norbert Wiedemann, Grégoire Vuagniaux, Philippe A. Gallay · 2020 · PLoS ONE
23. Highly dampened HIV-specific cytolytic effector T cell responses define viremic non-progression
    Amit Kumar Singh, Varsha Padwal, Harsha Chandrashekhar Palav, Shilpa Velhal, Vidya Sanjay Nagar, Priya Patil, Vainav V. Patel · 2022 · Immunobiology
24. Immune checkpoint analysis of T‐cell responses to pp65 and IE‐1 antigens in end‐stage lung diseases
    Laura Bergantini, Miriana d’Alessandro, Dalila Cavallaro, Elena Pordon, Lucia Cassai, Sara Gangi, Federica Meloni, Francesca Montagnani, Piero Paladini, Rosa Metella Refini et al. · 2022 · Scandinavian Journal of Immunology
25. PD-1 receptor on immune cells, its expression and potential role in cancer therapy
    D. S. Elezov, Igor Vladimirovich Kudryavtsev · 2019 · Cellular Therapy and Transplantation
26. Definition, Natural History and Heterogeneity of HIV Controllers
    Asier Sáez‐Cirión, Gianfranco Pancino, Olivier Lambotte · 2011 · Elsevier eBooks
27. PD-1 blockade enhances functional vaccine-induced HIV-1 CD8+ T-cell responses in PWH receiving early ART
    Miguel Ángel Marín, Alba Ruiz, Dan Ouchi, Esther Jiménez‐Moyano, Ruth Peña, Oscar Blanch-Lombarte, Dan Gorman, Richard Barnard, Tomáš Hanke, Bonaventura Clotet et al. · 2025 · EBioMedicine
28. SREBP1 knockdown triggers ferroptosis by suppressing the Nrf2-XCT/GPX4 axis in ovarian cancer
    Rui Nie, Houkun Zhou, Lin Chen, Haiyan Quan, Yuan Zhang, Zhenhua Lin · 2026 · Cell Death Discovery
29. Defective Antigen Presentation Leads to Upregulation of PD1 and IL-10 in HIV-TB Co-Infection
    Sharada Ramaseri Sunder, Naveenchandra Suryadevara, Satya Sudheer Pydi, Venkata Sanjeev Kumar Neela, Vijaya Lakshmi Valluri · 2020 · Journal of Interferon & Cytokine Research
30. Rhesus Cytomegalovirus-Specific CD8+ Cytotoxic T Lymphocytes Do Not Become Functionally Exhausted in Chronic SIVmac239 Infection
    Brandon C. Rosen, Núria Pedreño-López, Michael J. Ricciardi, Jason S. Reed, Jonah B. Sacha, Eva G. Rakasz, David I. Watkins · 2020 · Frontiers in Immunology
31. Transforming dysfunctional CD8+ T cells into natural controller–like CD8+ T cells: can TCF-1 be the magic wand?
    Hiroshi Takata, Lydie Trautmann · 2022 · Journal of Clinical Investigation
32. Modulation of T-Cell Mediated Immunity by Cytomegalovirus
    Chris A. Benedict, Ramon Arens, Andrea I. Loewendorf, Edith M. Janssen · 2011 · Springer eBooks
33. Gene expression profiling of murine T-cell lymphoblastic lymphoma identifies deregulation of S-phase initiating genes
    Magdalena Julia Dabrowska, Ditte Møller Ejegod, Louise Berkhoudt Lassen, Hans Erik Johnsen, Matthias R. Wabl, Finn Skou Pedersen, Karen Dybkær · 2013 · Leukemia Research
34. Induction of rapid apoptosis for class I MHC molecule-restricted CD8+ HIV-1 gp160-specific murine activated CTLs by free antigenic peptide in vivo
    Yohko Nakagawa, M. Shimizu, Yoshihiko Norose, Megumi Takahashi, Hidemi Takahashi · 2012 · International Immunology
35. Programming T cell Killers for an HIV Cure: Teach the New Dogs New Tricks and Let the Sleeping Dogs Lie
    Kellie Nicole Smith, Robbie B. Mailliard, Charles R. Rinaldo · 2015 · Forum on Immunopathological Diseases and Therapeutics
36. The Immunopathogenesis of HIV-1 Infection
    Rachel M. Presti, Giuseppe Pantaleo · 2016 · Elsevier eBooks
37. Killing Efficiency Affected by Mutually Modulated PD-1 and PD-L1 Expression via NKT-hepatoma Cell Interactions
    Liwei Liu, Mingya Yang, XU Qia, Min Zhou, Yan Cheng, Heming Xu, Yide Qin, Bo Liu · 2020 · Immunotherapy
38. Programmed Cell Death Protein 1 Axis Inhibition in Viral Infections: Clinical Data and Therapeutic Opportunities
    Konstantinos Tsiakos, Niki Gavrielatou, Ioannis Athanasios Vathiotis, Loukas G. Chatzis, Stamatios Chatzis, Garyphallia Poulakou, Elias Alexandros Kotteas, Nikolaos Konstantinos Syrigos · 2022 · Vaccines
39. HIV positivity may not have a negative impact on survival in Epstein‑Barr virus‑positive Hodgkin lymphoma: A Japanese nationwide retrospective survey
    Mihoko Yotsumoto, Yoshikazu Ito, Shotaro Hagiwara, Yasuhito Terui, Hirokazu Nagai, Yasunori Ota, Atsushi Ajisawa, Tomoko Uehira, Junko Tanuma, Kazuma Ohyashiki et al. · 2018 · Oncology Letters
40. Effect of lentivirus encoding HIV-1 Nef-U3 shRNA on the function of HIV-specific memory CD4+ T cells in patients with chronic HIV-1 infection
    Takuya Yamamoto, Assia Samri, Anne‐Geneviève Marcelin, Yu-ya Mitsuki, Vincent Cálvez, Brigitte Autran, Yasuko Tsunetsugu‐Yokota · 2009 · AIDS
41. Allogeneic gene-edited HIV-specific CAR-T cells secreting PD-1 blocking scFv enhance anti-HIV activity in vitro
    Hanyu Pan, Jing Wang, Huitong Liang, Zhengtao Jiang, Lin Zhao, Yanan Wang, Xinyi Yang, Zhiming Liang, Xiaoting Shen, Qinru Lin et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
42. From ex vivo to in vitro models: towards a novel approach to investigate the efficacy of immunotherapies on exhausted Vγ9Vδ2 T cells?
    Morgane Chauvet, Dorothée Bourges, Emmanuel Scotet · 2025 · Frontiers in Immunology
43. Ageing with HIV-1: immunological challenges for effective vaccination
    Pauline Saint-Charles, Arnaud M. Didierlaurent, Victor Appay · 2025 · Immunity & Ageing
44. Immune Responses to Persistent or Recurrent Antigens: Implications for Immunological Memory and Immunotherapy
    2021 · Frontiers research topics
45. Counterproductive effects of anti-CD38 and checkpoint inhibitor for the treatment of NK/T cell lymphoma
    Wendy W. L. Lee, Jing Quan Lim, Tiffany Pooi Ling Tang, Daryl Chen Lung Tan, Ser Mei Koh, Kia Joo Puan, Liang Wei Wang, Jackwee Lim, Kim Peng Tan, Wee Joo Chng et al. · 2024 · Frontiers in Immunology
46. Navigating the Roadblocks: Progress and Challenges in Cell‐Based Therapies for Human Immunodeficiency Virus
    Lakshay Chhabra, Rajeev Kumar Pandey, Rajiv Kumar, Shyam Sundar, Sanjana Mehrotra · 2024 · Journal of Cellular Biochemistry
47. Changes to the Simian Immunodeficiency Virus (SIV) Reservoir and Enhanced SIV-Specific Responses in a Rhesus Macaque Model of Functional Cure after Serial Rounds of Romidepsin Administrations
    Adam J. Kleinman, Sindhuja Sivanandham, Paola Sette, Ranjit Sivanandham, Benjamin B. Policicchio, Cuiling Xu, Ellen P. Penn, Egidio Brocca‐Cofano, Quentin Le Hingrat, Dongzhu Ma et al. · 2022 · Journal of Virology
48. Up-regulation of tim-3 expression contributes to development of burn-induced T cell immune suppression in mice
    Zhaohui Tang, Yu Yan, Wenhong Qiu, Jian Zhang, Xiang‐Ping Yang · 2011 · Journal of Huazhong University of Science and Technology [Medical Sciences]
49. Putting T cells to sleep: A new paradigm for immune evasion by persistent viruses
    Shweta Dubey, Shahid Jameel · 2006 · Journal of Biosciences
50. Chimpanzee CD4+ T cells are relatively insensitive to HIV‐1 envelope‐mediated inhibition of CD154 up‐regulation
    Erik Rutjens, Joost N. Vermeulen, Babs E. Verstrepen, Sam Hofman, Jan M. Prins, Indresh K. Srivastava, Jonathan Luke Heeney, Gerrit Koopman · 2008 · European Journal of Immunology
51. Differing HLA types influence inhibitory receptor signalling in CMV-specific CD8+ T cells
    Richard Macaulay, Natalie E. Riddell, Stephen Griffiths, Arne N. Akbar, Siân M. Henson · 2012 · Human Immunology
52. Are Affinity-Enhanced T Cells the Future of HIV Therapy?
    Angel Varela‐Rohena, Bent K. Jakobsen, Andrew Kelvin Sewell, Carl H. June, James L. Riley · 2009 · HIV Therapy
53. Influence of antiretroviral therapy on programmed death-1 (CD279) expression on T cells in lymph nodes of human immunodeficiency virus–infected individuals
    S. Ehrhard, Marion Wernli, Ursula Dürmüller, Manuel Battegay, Fred G. Gudat, Peter Erb · 2009 · Human Pathology
54. Deconvolving heterogeneity in the CD8+ T-cell response to HIV
    W. Nicholas Haining, R. Anthony Barnitz · 2011 · Current Opinion in HIV and AIDS
55. Dynamics and Correlates of CD8 T-Cell Counts in Africans with Primary Human Immunodeficiency Virus Type 1 Infection
    Heather A. Prentice, Hailin Lu, Matt A. Price, Anatoli Kamali, Etienne Karita, Shabir Lakhi, Eduard Joachim Sanders, Omu Aggrey Anzala, Susan A Allen, Paul Goepfert et al. · 2016 · Journal of Virology
56. Programmed cell death protein 1 (PD‐1) in infection
    S. Leth, S. Jensen-fangel · 2020 · Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS)
57. AIDS Vaccines
    Bruce D. Walker · 2016 · Elsevier eBooks
58. High frequencies of PMN-MDSCs are associated with low suppressive capacity in advanced stages of HIV-1 infection
    Eva M. Grützner, Ashley Neizert, Renate Stirner, Raffaele Conca, Immanuel Andrä, Lisa S. Wolff, Matthias Schiemann, Lesca Miriam Holdt, Christoph Klein, Johannes Richard Bogner et al. · 2020 · Translational Medicine Communications
59. CD8+ T-Cell Mediated Control of HIV-1 in a Unique Cohort With Low Viral Loads
    Amber D. Jones, Svetlana Khakhina, Tara Jaison, Erin Santos, Stephen M. Smith, Zachary A. Klase · 2021 · Frontiers in Microbiology
60. The Role of Exhaustion in Tumor-Induced T Cell Dysfunction in Cancer
    Heriberto Prado-Garcı́a, Susana Romero‐Garcia, José Sullivan López-González · 2014 · Springer eBooks
61. Programmed cell death-1 single-nucleotide polymorphism rs10204525 is associated with human immunodeficiency virus type 1 RNA viral load in HIV-1-infected Moroccan subjects
    Hanâ Baba, Anass Kettani, Meryem Bouqdayr, Ahd Ouladlahsen, Rajaa Bensghir, Latifa Marih, M. Sodqi, Soumaya Benjelloun, Sayeh Ezzikouri, Imane Zaidane et al. · 2021 · Medical Microbiology and Immunology
62. Human immunodeficiency virus vaccines
    Marc P Girard, Wayne Chester Koff · 2013 · Elsevier eBooks
63. BCL-2 Antagonism Sensitizes CTL-Resistant HIV Reservoirs to Elimination Ex Vivo
    Yanqin Ren, Szu-Han Huang, Shabnum Patel, Dean Magat, Amanda B. Macedo, Ryan Durga, Elizabeth A. Zale, Talia M. Mota, Ronald Truong, Thomas M. Rohwetter et al. · 2019 · SSRN Electronic Journal
64. Human Immunodeficiency Virus
    John Guatelli, Robert F. Siliciano, Daniel R. Kuritzkes, Douglas D. Richman · 2009 · Wiley eBooks
65. NEW INSIGHTS INTO CLASSICAL COSTIMULATION OF CD8+ T CELL RESPONSES.
    Christine M. Bucks, Peter D. Katsikis · 2008 · Advances in experimental medicine and biology
66. IL-27 effects on HIVGag-specific CD4 and CD8 T cell function
    Maryam Abdussamad, Grace Katz, Jie Cheng, Chinmayee Mehta, Fernando Andres-Martin, Danial Mahmood, Princy N. Kumar, Marta Catálfamo · 2025 · Frontiers in Virology
67. PD-1/PD-L1 blockade in HIV-associated advanced lung cancer: from mechanisms to clinical practice
    Ruifang Chen, Shuai Ren, Haicheng Tang, Qingguo Wu · 2026 · Frontiers in Immunology
68. Immunosuppressive Pathways in Cutaneous Melanoma: Functional Integration Between PD-1 and CD73 and Therapeutic Implications
    Rayana Vilela Bertolucci, Bruna Klein, Camilla Casarin Pase, Vitória Capelli de Melo, Margarete Dulce Bagatini · 2026 · Pharmaceuticals
69. Delipidated Retroviruses as Potential Autologous Therapeutic Vaccines—A Pilot Experiment
    Moiz Kitabwalla, Aftab Ahmed Ansari, Francois J. Villinger, Hassibullah Akeefe, Adam P. Conner, Ann E. Mayne, James E. K. Hildreth · 2008 · Experimental Biology and Medicine
70. T Cell Responses During Human Immunodeficiency Virus (HIV)-1 Infection
    Claire Anne Chougnet, Barbara L. Shacklett · 2011 · Springer eBooks
71. Evaluation of dual-serotype adenovirus-based vaccine-induced cellular immunity following preventative and therapeutic immunization against simian immunodeficiency virus
    Adam C. Soloff · 2008 · D-Scholarship@Pitt (University of Pittsburgh)
72. Immune Pathogenesis of Viral Hepatitis B and C
    Kyong‐Mi Chang · 2012 · Elsevier eBooks
73. Gene Expression Profiling of Murine T-Cell Lymphoblastic Lymphoma Identifies Deregulation of S-Phase Initiating Genes.
    Karen Dybkær, Magdalena Julia Dabrowska, Ditte Møller Ejegod, Louise Berkhoudt Lassen, Hans Erik Johnsen, Matthias R. Wabl, Finn Skou Pedersen · 2012 · Blood
74. The immunopathogenesis of HIV-1 infection
    Alexandre Harari, Giuseppe Pantaleo · 2010 · Elsevier eBooks
75. Novel therapeutic strategies against cancer and chronic infection by targeting P-selectin glycoprotein ligand-1 as an immune T cells response regulator
    Elisa Ramos‐Sevillano, José Yuste · 2016 · Translational Cancer Research
76. Divergence in CD8+ T cell epitopes of HIV -1 as an immune escape mechanism
    Bonnie A. Colleton · 2007 · D-Scholarship@Pitt (University of Pittsburgh)
77. Enhancing the Efficacy of Checkpoint Blockade Through Combination Therapies
    Vikram R. Juneja, Martin W. LaFleur, Robert T. Manguso, Arlene H. Sharpe · 2016 · Springer eBooks
78. Immunomodulatory effects of Tim-3 and PD-1 on chronic hepatitis B virus infection
    Yuan Liu · 2018 · Infection International/Infection International (Electronic Edition)
79. Dynamics of cellular immune responses in recipients of renal allografts positive for hepatitis B surface antigen
    Ya‐Wen Yang, Chien‐Chia Chen, Ching‐Yao Yang, Chih‐Yuan Lee, Hung‐Chih Yang, Bor‐Luen Chiang, Ya‐Hui Chuang, Tiffany E. Wu, Hong‐Shiee Lai, Meng‐Kun Tsai · 2021 · Journal of the Formosan Medical Association
80. Human Immunodeficiency Virus Vaccines
    Marc P Girard, Wayne Chester Koff · 2017 · Elsevier eBooks
81. Study of immunomics and immune regulation in ovarian cancer
    Abdul Aziz · 2013 · Spiral (Imperial College London)
82. Immune Mechanisms of Viral Clearance and Disease Pathogenesis During Viral Hepatitis
    Carlo I. Ferrari, Mario Umberto Mondelli · 2009 · Wiley eBooks
83. PD-1+ T cells: exhausted and premature?
    Lishan Su · 2007 · Blood
84. Immunosuppression: learning from the masters
    Chris A. Benedict, Edith M. Janssen · 2007 · Expert Review of Clinical Immunology
85. Editorial: Is HIV-1 induction of macrophage expression of PD-L1 and PD-L2 its weakest or strongest link to disease? HIV-1 plays both sides by augmenting and limiting T cell activation to survive in vivo
    Sean C. Patro, Luis J. Montaner · 2011 · Journal of Leukocyte Biology
86. Estudio de las vías de señalización de CD31 y PD-1 en la regulación de la respuesta inmune contra Mycobacterium tuberculosis
    Javier O. Jurado · 2010 · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)
87. Immunity leashed - mechanisms of regulation in the human immune system
    Eirik A. Torheim · 2010 · NORA - Norwegian Open Research Archives
88. The Role of Tim-3 Receptor in CD8+ T cells Cytotoxicity in Chronic HIV Infection
    Ali Sakhdari · 2013 · TSpace (University of Toronto)
89. The EZH2 inhibitor tazemetostat mitigates HIV immune evasion, reduces reservoir formation, and promotes durable CD8⁺ T-cell revitalization
    Andrea Gramatica, Itzayana G. Miller, Adam R. Ward, Khan Farzana, Tyler J. Kemmer, Jared Weiler, Tan Thinh Huynh, Paul Zumbo, Andrew P. Kurland, Louise Leyre et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
90. HIV-Associated Immune Exhaustion
    Victor Appay, Anna Lissina, Delphine Sauce · 2014 · Springer eBooks
91. HIV Nef amplifies mechanical heterogeneity to promote immune evasion
    Louise Leyre, Farah Mustapha, Alberto M. Herrera, Esther Lee, Emily M. Huntsman, Paul Zumbo, Jared Weiler, Parul Sinha, Ethan Naing, Connor Smith et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
92. Functional competence of CD8+ T cell responses specific to human cytomegalovirus in common variable immunodeficiency
    Sayed Mahdi Marashi · 2011 · UCL Discovery (University College London)
93. Design and Development of Recombinant Vaccines with Viral Properties
    Gerd Lipowsky, Martin F. Bachmann · 2011 · Wiley eBooks
94. Envolvimento de sinais co-estimulatórios na progressão das doenças periodontais humanas
    Eduardo Aleixo Figueira · 2007 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
95. Interdisciplinary characterization of T cell dynamics in HIV infection
    Marcus Buggert · 2014 · Figshare
96. The role of immune inhibitory receptors in age-associatedimmune decline
    Richard Macaulay · 2011 · UCL Discovery (University College London)
97. Einfluss von Viruslast und viralen Mutationen auf HIV-1 spezifische CD8 T-Zellen
    Thomas Vollbrecht · 2011
98. Dendritic cell responses to apoptotic cells : Is there life after death?
    Ulrika Johansson · 2010 · Figshare
99. Tim-3 Regulation of Cancer Immunity
    Kaori Sakuishi, Ana Carrizosa Anderson · 2014 · Springer eBooks
100. The role of programmed death ligand-1 (PD-L1/B7-H1) in regulating the immune responses against herpes simplex virus-1 (HSV-1)
     Sohyun Jeon · 2014 · D-Scholarship@Pitt (University of Pittsburgh)